Ryan Martins, Chief Financial Officer at 89bio, Inc. (ETNB), sold 1,480 shares at $14.41 ($21K) on 2023-02-08, disclosed to the SEC on 2023-02-10.
Scheduled sale ($21k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ETNB | SELL | 2023-02-22 | $35K | — | Filing → |
| ETNB | SELL | 2023-02-07 | $47K | — | Filing → |
| ETNB | SELL | 2023-01-05 | $149K | — | Filing → |